These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 503345

  • 1. [Anti-edema activity of injectable Venoruton in abdominal surgery].
    De Anna D, Liboni A, Paoli M, Pollinzi V, Malin L, Mannella P, Ambroso G, Oberhauser V.
    Minerva Chir; 1979 Oct 31; 34(20):1377-92. PubMed ID: 503345
    [Abstract] [Full Text] [Related]

  • 2. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
    Artaria LG.
    Klin Monbl Augenheilkd; 1982 Jun 31; 180(6):568-70. PubMed ID: 6752553
    [No Abstract] [Full Text] [Related]

  • 3. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
    Dobbins DE, Soika CY, Dabney JM.
    Microcirc Endothelium Lymphatics; 1984 Oct 31; 1(5):509-23. PubMed ID: 6546155
    [Abstract] [Full Text] [Related]

  • 4. [Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling].
    Kamenícek V, Holán P, Franĕk P.
    Acta Chir Orthop Traumatol Cech; 2001 Oct 31; 68(1):45-9. PubMed ID: 11706714
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
    Hackett AM, Griffiths LA, Luyckx AS, van Cauwenberge H.
    Arzneimittelforschung; 1976 Oct 31; 26(5):925-8. PubMed ID: 989368
    [Abstract] [Full Text] [Related]

  • 6. Anticatatonic effect of venoruton.
    Aley KO, Kulkarni SK.
    Methods Find Exp Clin Pharmacol; 1988 Apr 31; 10(4):263-5. PubMed ID: 2898576
    [Abstract] [Full Text] [Related]

  • 7. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders].
    Bopp J.
    Med Welt; 1977 Oct 14; 28(41):1660-4. PubMed ID: 927128
    [No Abstract] [Full Text] [Related]

  • 8. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
    ZFA (Stuttgart); 1981 Sep 20; 57(26):1758-60. PubMed ID: 7303836
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S, Guerrini M.
    Clin Ter; 1977 Feb 15; 80(3):229-55. PubMed ID: 852233
    [No Abstract] [Full Text] [Related]

  • 10. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
    Gábor M.
    Acta Pharm Hung; 1983 May 15; 53(3):115-20. PubMed ID: 6880764
    [No Abstract] [Full Text] [Related]

  • 11. Influence of 0-(beta-hydroxyethyl)-rutin on the oedema-inhibiting effect of indomethacin.
    Blazsó G, Gábor M.
    Acta Pharm Hung; 1994 Jul 15; 64(4):123-4. PubMed ID: 7976365
    [Abstract] [Full Text] [Related]

  • 12. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
    Lukjan H, Rość D, Chyzy R, Bodzenta A, Szpak A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985 Jul 15; 112(1):191-6. PubMed ID: 2581865
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
    Cappelli R, Pecchi S, Oberhauser V, Forconi S, Di Perri T.
    Int J Clin Pharmacol Res; 1987 Jul 15; 7(4):291-9. PubMed ID: 3596872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Early reoperation in abdominal surgery].
    Nocentini P, Borrelli D, Baldelli PG, Bayon A.
    Omnia Med Ther; 1968 Jul 15; 46(2):235-334. PubMed ID: 5739609
    [No Abstract] [Full Text] [Related]

  • 16. [Possibilities for pain reduction by the prevention of edemas and elimination of endogenous pain producing substances].
    Dieckmann J.
    Fortschr Med; 1978 Aug 03; 96(29):1475-80. PubMed ID: 669542
    [Abstract] [Full Text] [Related]

  • 17. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
    Pedersen FM, Hamberg O, Sørensen MD, Neland K.
    Ugeskr Laeger; 1992 Sep 14; 154(38):2561-3. PubMed ID: 1413183
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
    Bergqvist D, Hallböök T, Lindblad B, Lindhagen A.
    Vasa; 1981 Sep 14; 10(3):253-60. PubMed ID: 7025500
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
    Kienzler JL, Sallin D, Schifflers MH, Ghika A.
    Eur J Clin Pharmacol; 2002 Sep 14; 58(6):395-402. PubMed ID: 12242598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.